Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C.
Maurizio
M
Gabrielli
Luca
L
Santarelli
Michele
M
Serricchio
Diego
D
Leo
Paolo
P
Pola
Antonio
A
Gasbarrini
D000208:Acute Disease; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012206:Rhabdomyolysis / Q000139:chemically induced*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins